• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Bayer CEO Bill Anderson makes his mark with major restructuring, 'significant'...

cafead

Administrator
Staff member
  • cafead   Jan 18, 2024 at 11:12: AM
via Bayer is launching a sweeping business overhaul as the German conglomerate sees “no viable alternative.”

Bayer on Wednesday unveiled a restructuring of its organization that will “come at the expense of many managerial employees,” according to chairwoman of the executives committee on Bayer’s supervisory board, Barbara Gansewend.

article source